Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07125235 · ClinicalTrials.gov registry record · NA
Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial
A NA study of Behavioral Intervention and ART Adherence, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 270
- Enrollment target
- 1
- Study location
NCT07125235 is a NA study of Behavioral Intervention and ART Adherence that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 270 participants, below the 5,417-participant average among 3 other Behavioral Intervention trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07125235, a NA study of Behavioral Intervention and ART Adherence, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 270 participants
- Enrollment target
- 1
- Study location
Study Summary
Men who are living with HIV and use stimulants face many challenges and barriers that may interfere with remembering to take their HIV medication. Forgetting to take HIV medication puts men living with HIV at a greater risk of becoming virally unsuppressed. Researchers are doing this study to test if a remote intervention can help participants improve remembering to take their HIV medications and reduce the HIV viral load among men living with HIV who use stimulants.
Conditions Studied
Interventions
- BEHAVIORAL reSTART Objective Adherence Self-Monitoring and Postive Affect mHealth Intervention
- DEVICE urine tenofovir point-of-care self-test
Study Locations (1)
California
- University of California, San Francisco - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 270 participants |
| Start Date | 2026-02-09 |
| Est. Completion | 2028-07-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07125235
The ClinicalTrials.gov registry entry for NCT07125235 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 270 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 5,417-participant average among 3 other Behavioral Intervention trials with a reported enrollment target (95% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Behavioral Intervention appearing as the primary indexed condition, and to 2 interventions - of which reSTART Objective Adherence Self-Monitoring and Postive Affect mHealth Intervention is the first listed.
NCT07125235 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT07125235 about?
NCT07125235 is a clinical study titled "Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial". Men who are living with HIV and use stimulants face many challenges and barriers that may interfere with remembering to take their HIV medication. Forgetting to take HIV medication puts men living with HIV at a greater risk of becoming virally unsuppressed. Researchers are doing this study to test i...
What is the current status of trial NCT07125235?
This trial is currently recruiting. It is a NA study. The enrollment target is 270 participants. The study started on 2026-02-09. Estimated completion is 2028-07-30.
What conditions does trial NCT07125235 study?
This clinical trial studies the following conditions: Behavioral Intervention, ART Adherence, Viral Suppression of HIV Infection.
What interventions are being tested in trial NCT07125235?
The interventions under investigation include: reSTART Objective Adherence Self-Monitoring and Postive Affect mHealth Intervention (BEHAVIORAL), urine tenofovir point-of-care self-test (DEVICE).
Who is sponsoring clinical trial NCT07125235?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07125235 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Behavioral Intervention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.